Study protocol, randomized controlled trial: reducing symptom burden in patients with heart failure with preserved ejection fraction using ubiquinol and/or D-ribose-Reference-Cited by-同舟云学术

Study protocol, randomized controlled trial: reducing symptom burden in patients with heart failure with preserved ejection fraction using ubiquinol and/or D-ribose

Published:2018-04-02 Issue:1 Volume:18 Page:
ISSN:1471-2261
Container-title:BMC Cardiovascular Disorders
language:en
Short-container-title:BMC Cardiovasc Disord

Author:

Pierce Janet D.,Mahoney Diane E.,Hiebert John B.,Thimmesch Amanda R.^ORCID,Diaz Francisco J.,Smith Carol,Shen Qiuhua,Mudaranthakam Dinesh Pal,Clancy Richard L.

Funder

National Institute on Aging

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12872-018-0796-2.pdf

Reference45 articles.

1. Travessa AM, Falcao LF. Treatment of heart failure with reduced ejection fraction-recent developments. Am J Ther. 2015;Epub Ahead of Print (doi: https://doi.org/10.1097/MJT.0000000000000406 .

2. Farmakis D, Stafylas P, Giamouzis G, Maniadakis N, Parissis J. The medical and socioeconomic burden of heart failure: a comparative delineation with cancer. Int J Cardiol. 2016;203(279–81. https://doi.org/10.1016/j.ijcard.2015.10.172 .

3. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, et al. Heart disease and stroke Statistics-2016 update: a report from the American Heart Association. Circulation. 2015; https://doi.org/10.1161/CIR.0000000000000350 .